Blincyto (Blinatumomab) is a bispecific T-cell engager antibody used to treat Philadelphia chromosome-negative relapsed or refractory B-cell precursor acute lymphoblastic leukemia. Given as a continuous intravenous infusion. Supplied by A.K. Pharma — trusted cancer medicine wholesaler in Delhi.